LEADER 01128nam0-22003251i-450- 001 990002001840403321 005 20130321130733.0 035 $a000200184 035 $aFED01000200184 035 $a(Aleph)000200184FED01 035 $a000200184 100 $a20030910d1894----km-y0itay50------ba 101 0 $aita$cger 200 1 $aGrammatica tedesca della lingua parlata$emetodo Gaspey-Otto-Sauer$fC. M. Sauer, G. Ferrari 205 $a5. diligentemente riv. e accresciuta d'un vocabolario dal professor Pietro Motti 210 $aHeidelberg$cGiulio Grooss$d1894 215 $a437 p.$d20 cm 225 1 $aMetodo Gaspey-Otto-Sauer per lo studio delle lingue moderne 333 $aInclude un vocabolario del professor Pietro Motti 610 0 $aLingua tedesca$aGrammatica 676 $a435 700 1$aSauer,$bKarl Marquard$084535 701 1$aFerrari,$bGiuseppe$c$0428727 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990002001840403321 952 $a61 I B.9/07$b943$fDAGEN 959 $aDAGEN 996 $aGrammatica tedesca della lingua parlata$9403137 997 $aUNINA LEADER 07468 am 22007333u 450 001 9910337530503321 005 20230125193337.0 010 $a3-030-02278-1 024 7 $a10.1007/978-3-030-02278-5 035 $a(CKB)4100000007205024 035 $a(DE-He213)978-3-030-02278-5 035 $a(MiAaPQ)EBC5919513 035 $a(Au-PeEL)EBL5919513 035 $a(OCoLC)1132418197 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/30061 035 $a(PPN)235231657 035 $a(EXLCZ)994100000007205024 100 $a20181212d2019 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe EBMT Handbook$b[electronic resource] $eHematopoietic Stem Cell Transplantation and Cellular Therapies /$fedited by Enric Carreras, Carlo Dufour, Mohamad Mohty, Nicolaus Kröger 205 $a7th ed. 2019. 210 $aCham$cSpringer Nature$d2019 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (XL, 702 p. 56 illus., 38 illus. in color.) 311 $a3-030-02277-3 327 $aPart 1. Introduction -- 1. HSCT: Historical perspective -- 2. The EBMT: History, present and future -- 3. The role of unrelated donor registries in HSCT -- 4. The HSCT Unit -- 5. JACIE accreditation of HSCT programs -- 6. Statistical methods in HSCT and Cellular Therapies -- Part 2. Biological aspects -- 7. Biological properties of HSC: scientific basis for HSCT -- 8. Biological properties of cells other than HSC -- 9. Histocompatibility -- 10. Clinical & biological concepts for mastering Immune reconstitution after HSCT: towards practical guidelines and greater harmonization -- Part 3. Methodology and clinical aspects -- 11. Evaluation and counselling of candidates -- 12. Donor selection for adults and pediatrics -- 13. Conditioning -- 14. Bone marrow harvesting for HSCT -- 15. Mobilization and collection of HSC -- 16. Collection of HSC in children -- 17. Processing, cryopreserving, and controlling the quality of HSCs -- 18. Procurement and management of cord blood -- 19. Graft manipulation -- 20. Documentation of engraftment and chimerism after HSCT -- 21. Short and long-term controls after HSCT -- Part 4. General management of the patient -- 22. Vascular access -- 23. Transfusion support -- 24. Nutritional support -- 25. GVHD prophylaxis (immunosuppression) -- 26. Management ATG (SIRS) -- 27. Infections control and isolation procedures -- 28. General management of the patient; Specific aspects of children -- 29. Vaccinations -- 30. Psychological morbidity and support -- 31. Clinical relevant drug interactions in HSCT -- 32. Role of nursing in HSCT -- 33. Ethical issues in HSCT -- 34. Quality of life assessment after HSCT for pediatric and adults -- Part 5. HSCT complications and management -- 35. Neutropenic fever -- 36. Bacterial infections -- 37. Invasive fungal infections -- 38. Viral infections -- 39. Other life-threatening infections -- 40. Bleeding and thrombotic complications -- 41. Graft failure -- 42. Early complications of endothelial origin -- 43. Acute Graft-versus-Host Disease -- 44. Chronic Graft-versus-Host Disease -- 45. Post-transplant lymphoproliferative syndromes -- 46. Iron overload -- 47. Secondary neoplasia (other than PTLPS) -- Part 6. Specific organ complications -- 48. Ocular and oral complications -- 49. Hepatic complications -- 50. Gastrointestinal complications -- 51. Hemorrhagic cystitis and renal dysfunction -- 52. Non-infectious pulmonary complications -- 53. Neurological complications -- 54. Skin, hair and musculoskeletal complications -- 55. Cardiovascular diseases and metabolic syndrome -- 56. Endocrine disorders, fertility and sexual health -- Part 7. Prevention and management of relapse -- 57. Monitoring MRD in ALL and AML -- 58. Preventing/treating relapse with drugs -- 59. Delayed transfer of immune cells, or the art of Donor Lymphocyte Infusion -- 60. Cellular therapy with engineered T cells, efficacy and side effects -- 61. Mechanisms of Immune resistance -- 62. Regulatory Aspects of ATMP versus minimally manipulated immune cells -- Part 8. Specific modalities of HSCT and management -- 63. At-home HSCT -- 64. Umbilical cord blood transplantation in children and adults -- 65. Haploidentical HSCT -- 66. Photopheresis in adults and pediatrics -- 67. Overweight and obese patients -- 68. HSCT in elderly patients -- Part 9. Indications and results -- 69. Acute Myeloid Leukemia in adults -- 70. Acute Myeloid Leukemia in children -- 71. Acute Lymphoblastic Leukemia in adults -- 72. Acute lymphoblastic leukemia in children and adolescents -- 73. Myelodysplastic syndromes -- 74. Pediatric MDS including Refractory Cytopenia and Juvenile Myelomonocytic Leukemia -- 75. Myelodysplastic/myeloproliferative neoplasms -- 76. Myeloproliferative neoplasms -- 77. Severe aplastic anemia and PNH -- 78. Fanconi anemia and other hereditary Bone Marrow Failure syndromes -- 79. Hemoglobinopathies (Sickle Cell Disease and Thalassemia) -- 80. Multiple myeloma -- 81. Systemic light chain amyloidosis -- 82. POEMS syndrome and disease produced by other monoclonal immunoglobulins -- 83. Follicular lymphoma -- 84. Chronic lymphocytic leukemia -- 85. Diffuse large B cell lymphoma -- 86. Mantle cell lymphoma -- 87. Other T- and B-aggressive lymphomas and lymphomas associated to HIV -- 88. Classical Hodgkin?s lymphoma -- 89. Primary immunodeficiencies -- 90. Inborn error of metabolism and osteopetrosis -- 91. Autoimmune disease -- 92. Solid tumors. 330 $aThis Open Access 7th edition of the European Society for Blood and Marrow Transplantation (EBMT) handbook addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy. Consisting of 93 chapters, it has been written by 175 leading experts in the field. Discussing all types of stem cell and bone marrow transplantation, including haplo-identical stem cell and cord blood transplantation, it also covers the indications for transplantation, the management of early and late complications as well as the new and rapidly evolving field of cellular therapies. This book provides an unparalleled description of current practices to enhance readers? knowledge and practice skills. 606 $aHematology 606 $aSurgical transplantation 606 $aBlood transfusion 606 $aPediatric surgery 606 $aSurgical oncology 606 $aHematopoietic Stem Cell Transplantation 606 $aLeukemia$xtherapy 610 $aMedicine 610 $aHematology 610 $aSurgical transplantation 610 $aBlood transfusion 610 $aPediatric surgery 610 $aSurgical oncology 615 0$aHematology. 615 0$aSurgical transplantation. 615 0$aBlood transfusion. 615 0$aPediatric surgery. 615 0$aSurgical oncology. 615 12$aHematopoietic Stem Cell Transplantation. 615 22$aLeukemia$xtherapy. 676 $a616.15 700 $aCarreras$b Enric$4edt$01322568 702 $aCarreras$b Enric 702 $aDufour$b Carlo 702 $aMohty$b Mohamad 702 $aKröger$b Nicolaus 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910337530503321 996 $aThe EBMT Handbook$93359543 997 $aUNINA LEADER 02683 am 2200769 n 450 001 9910214921403321 005 20170105 010 $a2-86906-454-3 024 7 $a10.4000/books.pufr.3799 035 $a(CKB)3710000001633552 035 $a(FrMaCLE)OB-pufr-3799 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/47568 035 $a(PPN)202672980 035 $a(EXLCZ)993710000001633552 100 $a20170601j|||||||| ||| 0 101 0 $afre 135 $auu||||||m|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aLes fictions du réel dans le monde anglo-américain de 1960 à 1980 /$fJean-Paul Regis, Maryvonne Menget, Marc Chenetier 210 $aTours $cPresses universitaires François-Rabelais$d2017 215 $a1 online resource (116 p.) 330 $aRéel et fiction, statuts respectifs du langage (du logos, du verbe) et de la réalité, ces questions ont préoccupé philosophes et théologiens pendant des siècles. Pourtant nous allons, une fois encore, en emprunter les sentiers souvent parcourus parce que de nouvelles voies, de nouvelles perspectives ont été ouvertes au cours des vingt dernières années en Grande-Bretagne, aux États-Unis, et dans le monde occidental d'une façon générale. 606 $aArt 606 $aCultural studies 606 $afiction 606 $aréel 606 $asociologue 606 $aromancier 606 $asculpteur 606 $aphotographe 606 $apoète 610 $asculpteur 610 $afiction 610 $aromancier 610 $aréel 610 $aphotographe 610 $apoète 610 $asociologue 615 4$aArt 615 4$aCultural studies 615 4$afiction 615 4$aréel 615 4$asociologue 615 4$aromancier 615 4$asculpteur 615 4$aphotographe 615 4$apoète 700 $aCoëllier$b Sylvie$01291213 701 $aCohen-Safir$b Claude$01301713 701 $aCordesse$b Gérard$01301714 701 $aD'haen$b Theo$01301715 701 $aDelechelle$b Gérard$01285405 701 $aKempf$b Jean$01286390 701 $aMason$b Timothy$0302548 701 $aMenget$b Maryvonne$01285419 701 $aRégis$b Jean-Paul$01286396 701 $aRuf-Burac$b Liliane$01301716 701 $aRegis$b Jean-Paul$01286396 701 $aMenget$b Maryvonne$01285419 701 $aChenetier$b Marc$01291212 801 0$bFR-FrMaCLE 906 $aBOOK 912 $a9910214921403321 996 $aLes fictions du réel dans le monde anglo-américain de 1960 à 1980$93025997 997 $aUNINA